Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes

The long terminal repeat (LTR) of the human immunodeficiency virus (HIV) contains three binding sites for the transcriptional factor Sp1. In order to investigate the role that the Sp1-binding sites play in regulation of HIV replication, we have introduced a deletion of all three Sp1-binding sites into the LTR of an infectious molecular clone of HIV. Viral stocks have been prepared from this mutant virus, designated dl-Sp, and these stocks have been used to study its replicative ability in human T cells. The dl-Sp virus replicated efficiently in MT4 cells and in phytohemagglutinin-stimulated human peripheral blood lymphocytes, but it replicated poorly and with delayed kinetics in A3.01 (CEM) T cells unless those cells had been treated with the cytokine tumor necrosis factor alpha. Gel retardation assays to study the levels of DNA-binding proteins present in these cells showed that NF-kappa B activity could be detected in the nuclei of MT4 cells but not in A3.01 cells unless they had been treated with tumor necrosis factor alpha. Thus, the presence of NF-kappa B activity appeared to be required for efficient replication of an HIV whose LTR Sp1-binding sites had been deleted. This suggests that NF-kappa B can functionally compensate for Sp1 in activating HIV replication. The HIV LTR is therefore similar to the promoter-enhancer units of other viruses in that it is composed of multiple functional elements that may contribute differently to viral replication depending on the levels of DNA-binding proteins present in the target cells.

[1]  B. Berkhout,et al.  TAR-independent activation of the HIV-1 LTR: Evidence that Tat requires specific regions of the promoter , 1990, Cell.

[2]  E. Golemis,et al.  Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. , 1990, Genes & development.

[3]  R. Tjian,et al.  Synergistic activation by the glutamine-rich domains of human transcription factor Sp1 , 1989, Cell.

[4]  J. Leonard,et al.  The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity , 1989, Journal of virology.

[5]  K. Jones.  HIV trans-activation and transcription control mechanisms. , 1989, The New biologist.

[6]  P. Sharp,et al.  HIV TAR: An RNA enhancer? , 1989, Cell.

[7]  N. Manley,et al.  Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus , 1989, Journal of virology.

[8]  E K Ross,et al.  Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120 , 1989, Journal of virology.

[9]  B. Cullen,et al.  Regulatory pathways governing HIV-1 replication , 1989, Cell.

[10]  W. Dynan.  Modularity in promoters and enhancers , 1989, Cell.

[11]  G. Soma,et al.  Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication , 1989, Journal of virology.

[12]  T. Okamoto,et al.  Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha. , 1989, AIDS research and human retroviruses.

[13]  J. Justement,et al.  Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Golemis,et al.  Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses , 1989, Journal of virology.

[15]  D. Baltimore,et al.  NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Gendelman,et al.  Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence , 1988, Journal of virology.

[17]  P. Chambon,et al.  Cooperativity and hierarchical levels of functional organization in the SV40 enhancer , 1988, Cell.

[18]  H. Varmus,et al.  Regulation of HIV and HTLV gene expression. , 1988, Genes & development.

[19]  R. Gaynor,et al.  Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP‐1 and UBP‐1. , 1988, The EMBO journal.

[20]  R. Roeder,et al.  Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[21]  W. Herr,et al.  The SV40 enhancer contains two distinct levels of organization , 1988, Nature.

[22]  R. Gaynor,et al.  Alterations in binding characteristics of the human immunodeficiency virus enhancer factor , 1988, Journal of virology.

[23]  P. Earl,et al.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity , 1988, Journal of virology.

[24]  M. Karin,et al.  In vitro activation of the HIV‐1 enhancer in extracts from cells treated with a phorbol ester tumor promoter. , 1987, The EMBO journal.

[25]  J. Justement,et al.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. , 1987, Science.

[26]  P. Luciw,et al.  Human immunodeficiency virus long terminal repeat responds to T-cell activation signals. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Kaufman,et al.  Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element , 1987, Molecular and cellular biology.

[28]  N. Holbrook,et al.  Binding of a cellular protein to the gibbon ape leukemia virus enhancer , 1987, Molecular and cellular biology.

[29]  D. Capon,et al.  Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein , 1987, Cell.

[30]  P. Luciw,et al.  Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Pavlakis,et al.  Expression and characterization of the trans-activator of HTLV-III/LAV virus. , 1986, Science.

[32]  Bryan R. Cullen,et al.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism , 1986, Cell.

[33]  R. Tjian,et al.  Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. , 1986, Science.

[34]  M. Wintzerith,et al.  Multiple sequence motifs are involved in SV40 enhancer function. , 1986, The EMBO journal.

[35]  S. Arya,et al.  Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). , 1985, Science.

[36]  K. Sell,et al.  Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Sodroski,et al.  The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat , 1985, Cell.

[38]  L. Ratner,et al.  Characterization of long terminal repeat sequences of HTLV-III. , 1985, Science.

[39]  M. Smith,et al.  Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template. , 1984, DNA.

[40]  D. Dorsett,et al.  Quantitation of a simian virus 40 nonhomologous recombination pathway , 1983, Journal of virology.

[41]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[42]  B. Hirt.  Selective extraction of polyoma DNA from infected mouse cell cultures. , 1967, Journal of molecular biology.

[43]  B. Franza,et al.  Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay , 1987, Nature.

[44]  R. Roeder,et al.  Eukaryotic gene transcription with purified components. , 1983, Methods in enzymology.